Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
about
Intranasal ketorolac tromethamine (SPRIX(R)) containing 6% of lidocaine (ROX-828) for acute treatment of migraine: safety and efficacy data from a phase II clinical trial.Almotriptan and zolmitriptan in the acute treatment of migraine.A novel test to compare two treatments based on endpoints involving both nonfatal and fatal events.Almotriptan in the treatment of migraine.Almotriptan for the treatment of acute migraine: a review of early intervention trials.Treatment strategies for menstrually related migraine.
P2860
Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Focus on trial endpoints of cl ...... e acute treatment of migraine.
@ast
Focus on trial endpoints of cl ...... e acute treatment of migraine.
@en
type
label
Focus on trial endpoints of cl ...... e acute treatment of migraine.
@ast
Focus on trial endpoints of cl ...... e acute treatment of migraine.
@en
prefLabel
Focus on trial endpoints of cl ...... e acute treatment of migraine.
@ast
Focus on trial endpoints of cl ...... e acute treatment of migraine.
@en
P2093
P2860
P1476
Focus on trial endpoints of cl ...... e acute treatment of migraine.
@en
P2093
P2860
P304
P356
10.1111/J.1368-5031.2005.00692.X
P577
2005-11-01T00:00:00Z